A generic alternative indicated for Heart & Blood Pressure. This clinical formulation prevents blood clotting to reduce the risks of thrombotic events such as stroke or myocardial infarction.
Indicated to address platelet clumping to support heart health and mitigate the risk of repeat heart attacks and strokes in high-risk adult patients.
Mechanism of Action
Ticagrelor prevents platelets in the blood from sticking together to form a dangerous clot. It works differently from some other drugs because its effect is reversible, meaning the blood returns to normal faster after stopping.
Route of Administration
Oral
Onset Time
1.5–2 hours
Duration
12–24 hours
Contraindications
Active pathological bleeding, History of intracranial hemorrhage, Severe liver impairment
Severe Adverse Events
Major internal bleeding, Severe gastrointestinal hemorrhage, Cardiac rhythm disorders (Bradycardia), Severe allergic reactions
Common Side Effects
Easy bruising, Bleeding from small cuts
Uncommon Side Effects
Shortness of breath (Dyspnea), Nosebleeds, Dizziness, Nausea, Skin rash
Information for Brilinta is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
